![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Co-Diagnostics’ COVID-19 Test Gets EUA
Co-Diagnostics’ COVID-19 Test Gets EUA
![emergency use authorization approved](https://www.fdanews.com/ext/resources/test/Drug-Images4/emergency-use-authorization-EUA-approved.gif?t=1586211479&width=430)
The FDA has granted Co-Diagnostics an emergency use authorization for its COVID-19 test.
The Logix Smart test, which previously received a CE Mark, is now cleared for use in the U.S. by certified clinical laboratories.
The test targets the RdRp gene of the coronavirus and uses the company’s patented technology to significantly reduce amplification errors.
Upcoming Events
-
21Oct